A stake cap excludes some preferred holdings from Minerva Neurosciences (NERV)'s ownership tally.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Coastlands Capital LP and its affiliates have filed an amended Schedule 13G/A, reporting a 9.99% beneficial ownership stake in Minerva Neurosciences (NERV). This ownership includes common shares issuable from Series A Convertible Preferred Stock, but explicitly excludes additional preferred shares and warrants due to a 9.99% beneficial ownership limitation.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.